INTRODUCTION
T he gastric cancer is the most frequent neoplasia of the digestive tract and about 60% of the cases are advanced tumours, when patients are firstly admitted in out-patient ambulatory. The incidence of the disease decreased in some countries to occupy the second position and is currently the third most common malignant tumor worldwide, with approximately 870 000 new cases per year. In men, the incidence is twice higher than in women. The geographical distribution of stomach cancer is characterized by its wide international variation. The country with the highest incidence is Japan (77.9 per 100.000 in men and 33.3 per 100.000 in women), but high rates are also observed in Central America, South America and East Asia.In China, it is the highest incidence (43.7 per 100,000 in men and 18.9 per 100,000 in women) 1, 2, 3 . In Brazil, official records show that cancer rates highest average annual age-adjusted incidence per 100 000 men were found in São Paulo -SP (1997-1998: 38.8), Federal District -DF (1996 to 1998: 32, 7) and Belém -PA (1996-1998: 27.6). In the female population, the highest rates were observed in São Paulo (1997-1998: 15 3, 4 . The adenocarcinoma is the most commom histopatologic type. Considering the gastric location, the tumour is most common in the lower part of the stomach, followed by middle and the upper part 1, 4 . The best choice is a surgical and radical treatment, performing a subtotal or a total gastrectomy associated to an extended lymph node dissection, performing a DII lymphadenectomy 4, 5 . However, if the patients have an unresectable, stenosing and advanced tumour, are indicated palliative surgeries. The classic operation employed when the lesion is located in the lower part of the stomach is a latero-lateral gastroenteroanastomosis (Figure 1 ), that facilitates the gastric emptying, but frequently causes reflux of enteric contents into the stomach and the patients complains of epigastric pain and burnings. To avoid these symptoms another option is a Roux-en-Y latero-lateral gastroenteroanastomosis 4, 6, 7 .
The objective of this study is a retrospective analysis of patients with stenosing, unresectable and advanced gastric adenocarcinoma, performing Rouxen-Y anastomosis.
METHODS
From January / 1998 to December / 2009 it was reviewed 62 patients with advanced and unresectable gastric adenocarcinoma, submitted to an elective latero-lateral Roux-en-Y gastrojejunoanastomosis ( Figure 2 ). The age varied from 42 to 82 years (57.2 year-old average), and 43 were male (69.3%). All of the cases presented important gastric stasis and vomits, making difficult the ingestion of any king of foods. Nine cases (14,5%) presented hepatic metastasis. Preferentially the gastrojejunal anastomosis was pre-colic, in the great curvature and in the posterior wall of the stomach, in an area free from neoplasia. The jejunojejunoanastomosis was end-to-side anastomosis, about 50 cm from the stomach. In 14 cases (22.5%) the anastomosis were made in the anterior wall of the great curvature. One case previously submitted the latero-lateral gastrojejunastomosis, it was re-operated in 10 th day due to uncontrollable bilious vomits, performed Rouxen-Y reconstruction, with significant improvement of the alimentary ingestion. There were no fistulas and no mortality. The figures 3, 4, 5, 6 and 7 show the technique of the anastomosis. 
RESULTS
After surgery, liquids were introduced in the second or third postoperative day, and the major part of patients were discharged on sixth or seventh day. The medium period of hospitalization was of 7.5 days.
One death was recorded (1.6%), secondary to the pneumonia and sepsis.
Later, all patients ingested foods and pastes with weight gain. However, 12 cases (19.3%) they still referred abdominal fullness. The occurrence of frequent vomits was referred by four patients (6.4%), getting better with ingestion of liquid feeding. The chemotherapy was indicated in 47 cases (75%). The follow-up varied from three months to 26 months, and until the moment the medium survival was of 11 months.
DISCUSSION
Gastric cancer is a serious disease that sometimes has a rapid progression and its diagnosis is confirmed at an advanced stage. About 50% of all cases do not permit a curative procedure and a palliative surgery is necessary method to improve life quality 1, 6, 7 . There are many options of palliative treatment in advanced gastric cancer: gastrostomy, jejunostomy, total gastrectomy or sub-total gastrectomy with only tumour resection and bypass 4, 6 . Uslar et al 6 . analyzed a gastrectomy as a palliative treatment in patients diagnosed with an advanced gastric cancer. They showed that mean medium period of hospitalization was 17 days, morbidity 5,6%, mortality 18% and medium survival 4,7 months.
Restitution of digestive tract after gastrectomy can be performed by three techniques: Billroth I, Billroth II and Roux-en-Y. D'Amato et al. 7 comparing the three The advantages of Roux-en-Y reconstruction after a distal gastrectomy include a reduction of reflux gastritis and esophagitis, a decreased probability of gastric cancer recurrence, and a reduction in the incidence of surgical complications. The disadvantages of Roux-en-Y reconstruction include the possible development of stomal ulcer, an increased probability of cholelithiasis, increased difficulty with an endoscopic approach to the Vater´s ampulla, and the possibility of Roux stasis syndrome 8, 9, 10, 11 . And the authors recorded also an effective reducing of enteric reflux to the stomach and Helicobacter pylori infection 10 . Some publications in the past emphasized that the Roux-en-Y reconstruction causes delayed gastric emptying, called Roux stasis syndrome. However in this series, the majority of patients referred they could eat solid and pasty food easily 11, 12, 13 . According to the results of this study, in which a Roux-en-Y anastomosis was performed, a shorter period of hospitalization (7.5 days), lower mortality (1.6%) and longer survival (medium 9 months) were observed.
Were not found in the literature no publications focusing on this specific technique of gastric drainage, therefore, did not allow any comparison of results.
CONCLUSIONS
The Roux-en-Y gastrojejunoanastomosis is a good option in the sense of preventing the occurrence of vomits and regurgitations of enteric, bilious and pancreatic secretions in the postoperative period of palliative surgeries, in the stenosing and advanced gastric adenocarcinoma, improving they life quality, weight gaining.
